Literature DB >> 29925941

Author Correction: Comprehensive molecular profiling of lung adenocarcinoma.

.   

Abstract

In Supplementary Table 7 of this Article, the iCLUSTER output column contained incorrected cluster labels. This table has been corrected online. Corrected online 08 October 2014 - The surname of author Kristen Rodgers was misspelled 'Rogers'. This has been corrected online.

Entities:  

Year:  2018        PMID： 29925941     DOI： 10.1038/s41586-018-0228-6

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


  13 in total

1.  Examination of Combined Treatment of Ginsenoside Rg3 and 5-Fluorouracil in Lung Adenocarcinoma Cells.

Authors:  Kuizhong Shan; Yujiang Deng; Zhiquan Du; Peiyu Yue; Sufang Yang
Journal:  Comput Math Methods Med       Date:  2022-06-28       Impact factor: 2.809

2.  Co-expression patterns explain how a basic transcriptional role for MYC modulates Wnt and MAPK pathways in colon and lung adenocarcinomas.

Authors:  Melanie Haas Kucherlapati
Journal:  Cell Cycle       Date:  2022-04-19       Impact factor: 5.173

3.  Effect of ERCC2 rs13181 and rs1799793 polymorphisms and environmental factors on the prognosis of patients with lung cancer.

Authors:  Haorui Zhang; Yutao Li; Shicheng Guo; Yi Wang; Haijian Wang; Daru Lu; Jiucun Wang; Li Jin; Gengxi Jiang; Junjie Wu; Yiping Han; Juhong Li
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

4.  Expression and Gene Regulation Network of Adenosine Receptor A2B in Lung Adenocarcinoma: A Potential Diagnostic and Prognostic Biomarker.

Authors:  Yutong Sui; Jiayin Liu; Jing Zhang; Zena Zheng; Ziwei Wang; Zhenghu Jia; Ziyu Meng
Journal:  Front Mol Biosci       Date:  2021-07-19

5.  Modulation of proliferation factors in lung adenocarcinoma with an analysis of the transcriptional consequences of genomic EGFR activation.

Authors:  Melanie Haas Kucherlapati
Journal:  Oncotarget       Date:  2019-12-10

6.  Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism-related genes.

Authors:  Zhihao Wang; Kidane Siele Embaye; Qing Yang; Lingzhi Qin; Chao Zhang; Liwei Liu; Xiaoqian Zhan; Fengdi Zhang; Xi Wang; Shenghui Qin
Journal:  Cancer Cell Int       Date:  2021-04-15       Impact factor: 5.722

7.  Rac-GEF/Rac Signaling and Metastatic Dissemination in Lung Cancer.

Authors:  Mariana Cooke; Martin J Baker; Marcelo G Kazanietz
Journal:  Front Cell Dev Biol       Date:  2020-02-25

8.  miR-24-3p/KLF8 Signaling Axis Contributes to LUAD Metastasis by Regulating EMT.

Authors:  Pengyu Jing; Nianlin Xie; Nan Zhao; Ximing Zhu; Pei Li; Guizhou Gao; Haizhou Dang; Zhongping Gu
Journal:  J Immunol Res       Date:  2020-04-28       Impact factor: 4.818

9.  Association of PD-1 polymorphisms with the risk and prognosis of lung adenocarcinoma in the northeastern Chinese Han population.

Authors:  Kun Huang; Erqiang Hu; Wan Li; Junjie Lv; Yuehan He; Gui Deng; Jinling Xiao; Chengcheng Yang; Xinyu Zhao; Lina Chen; Xinyan Wang
Journal:  BMC Med Genet       Date:  2019-11-12       Impact factor: 2.103

10.  Complementary Sequential Circulating Tumor Cell (CTC) and Cell-Free Tumor DNA (ctDNA) Profiling Reveals Metastatic Heterogeneity and Genomic Changes in Lung Cancer and Breast Cancer.

Authors:  Say Li Kong; Xingliang Liu; Swee Jin Tan; Joyce A Tai; Ler Yee Phua; Huay Mei Poh; Trifanny Yeo; Yong Wei Chua; Yu Xuan Haw; Wen Huan Ling; Raymond Chee Hui Ng; Tira J Tan; Kiley Wei Jen Loh; Daniel Shao-Weng Tan; Quan Sing Ng; Mei Kim Ang; Chee Keong Toh; Yi Fang Lee; Chwee Teck Lim; Tony Kiat Hon Lim; Axel M Hillmer; Yoon Sim Yap; Wan-Teck Lim
Journal:  Front Oncol       Date:  2021-07-16       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.